Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Swedberg

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
European Heart Journal|March 14, 2003
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatmentM Komajda, F Follath, K Swedberg, et al.
European Heart Journal|August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryB A Bart, G Ertl, P Held, et al.
European Heart Journal|March 14, 2003
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosisJ G F Cleland, K Swedberg, F Follath, et al.
American Heart Journal|March 31, 2000
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitorsC B Granger, G Ertl, J Kuch, et al.
Journal of the American College of Cardiology|June 7, 2000
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative GroupR Latini, G Tognoni, A P Maggioni, et al.
The American Journal of Cardiology|November 6, 2001
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint dataV J Dzau, K Bernstein, D Celermajer, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
European Heart Journal|March 14, 2003
The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatmentM Komajda, F Follath, K Swedberg, et al.
European Heart Journal|August 17, 1999
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryB A Bart, G Ertl, P Held, et al.
European Heart Journal|March 14, 2003
The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosisJ G F Cleland, K Swedberg, F Follath, et al.
American Heart Journal|March 31, 2000
Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitorsC B Granger, G Ertl, J Kuch, et al.
Journal of the American College of Cardiology|June 7, 2000
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative GroupR Latini, G Tognoni, A P Maggioni, et al.
The American Journal of Cardiology|November 6, 2001
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint dataV J Dzau, K Bernstein, D Celermajer, et al.
American Heart Journal|June 20, 2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events, , S Connolly, et al.
The New England Journal of Medicine|July 8, 2011
Effect of nesiritide in patients with acute decompensated heart failureC M O'Connor, R C Starling, A F Hernandez, et al.
Pageof 22